<p>can endanger human health if they contain antibiotic residues in livestock products that can cause resistance to germs in the human body when consuming them. Along with the enactment of a policy to limit the use of antibiotics in animal feed, the use of probiotics as a substitute is urgently needed. This research has been conducted in the Research Center for Veterinary Science in<br />order to produce probiotic candidates to control the growth of Salmonella sp in chickens that have the potential to pollute the environment and cause foodborne disease. Research on probiotics in chicken has conducted in Indonesian Research Center for Veterinary Science in order to produce probiotic candidates to control the growth of Salmonella sp. in chicken that potentially contaminated the environment causing foodborne disease. The present study aims to evaluate the probiotic potential of indigenous bacteria isolated from cattle in Bogor and select candidates to be used as probiotic. The study was initiated by screening local<br />isolates for probiotic, following by inhibition test against a target of pathogenic bacteria (Salmonella enterica serotype of Typhimurium B0046/ATCC 13311 and serotype of Enteritidis B2893/ATCC 13076), pathogenicity in vitro, survival in the<br />chicken gut, and the lifespan in the lyophilized container. The results showed that six isolates bacteria consisting of Aerococcus viridans B2776, Bifidobacterium dentium B2754 and B2755, Enterococcus faecium B2758, Lactobacillus casei B2752, and Streptococcus uberis B2757 had been selected as the candidate for probiotics. They had specifications namely: anti-microbial<br />substance (in vitro) against S. enterica serotype Typhimurium BCC B0046 and serotype Enteritidis BCC B2893, not pathogenic, able to form colonies in intestinal broilers for 40 days with concentrations of >1010 CFU/gram with lifespan up to one year (lyophilized), using protectant serum of inositol 5% or 7,5% skim milk at 5C with concentrations >log10 CFU/ml. The potential<br />characteristics qualified them as probiotics against pathogenic bacteria and could be used to control salmonellosis in the broiler.</p>
Colibacillosis is considered important in the poultry industry because it generates economic losses due to the disturbance of growth, the decline in production, an increase number of culled chicken, and reduced quality of carcasses and eggs. Study of colibacillosis and antibiotics resistance patterns in broiler was conducted at the Indonesian Research Centre for Veterinary Science. The aim of the study was to provide the latest information on the status of the presence of Escherichia coli in broiler farms in four districts in West Java Province as well as its antibiotics drug resistance patterns and their pathogenicity will be studied. A total of 196 samples of the intestine, liver, heart, egg yolk, air sac that showed gross abnormalities were sampled and feces were collected and used in this study. Escherichia coli was isolated for characterisation and antibiotics drug resistance patterns and their pathogenicity were investigated. Escherichia coli were recovered from 149 (76.02%) samples out of the total samples collected. In this present study, one (7.7%) E. coli isolate was serologically typed into O 78 and 12 of them were untypable whereasthe other 7 (4.93%) isolates were serologycally typed into O 157 and 135 were untypable. In vitro pathogenicity indicated that 91.55% of the isolates were positive for Congo red binding assay and 4.93% isolates were positive for haemolysine production. Antibiogram profiles indicated that 98.70, 79.30, 75.10, 61.40, and 57.70% isolates were resistance against to amphicillin, neomycin, streptomycin, sulfamethoksazol trimethropim, and kanamycin, respectively. A total of 149 (76,02%) histopathologically had consistent colibacillosis lesion with various degree of severity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.